Moonshots Unveiled

Bite sized, bold, off beat bets

READ THIS FIRST: If you’re receiving this email, it’s because I think that you might like this content and I want to know what sucks about this newsletter. Don’t tell me what I want to hear, I won’t be offended.

Moonshots is a monthly newsletter spotlighting 4 asymmetric opportunities in the equity markets and 1 high-risk crypto flyer. These are concise ideas to get the juices flowing so DYOR—not financial advice.

Zero to Hero: Robinhood Account

Every month I am going to list my trades and try and grow my account from $183.55 to $50k by 2026. A tall task, but we’re up for it and I’ll describe my methodology along the way.

TRADES OF THE MONTH:

  • Jan 3 - SELL - $MSTR - PNL: -$7

  • Jan 3 - BUY - $COIN ($182 @ $268.86/share). Reasoning - Wallstreet underpricing administration change and EPS estimates are wildly inaccurate based on on-chain activity that they seem to not be tracking. Looking for a 50% increase to start the year off. Credit to @CBduck.base.eth for the due diligence and idea:

Moonshot #1 (Subscriber Submission)— Innoviz Technologies Ltd. (NASDAQ: INVZ): Innoviz develops solid-state LiDAR and perception software for autonomous vehicles.

Bull Catalysts for Innoviz Technologies:

  • Tier-1 LiDAR supplier with direct OEM ties

  • Regulatory mandates (AEB by 2029)

  • High integration barriers (sticky OEM partnerships)

  • S-curve adoption forecast (2026–2029)

  • OEM-backed NRE deals validate growth potential

TL;DR - Innoviz is a leading Tier-1 LiDAR supplier, benefiting from regulatory mandates, high entry barriers, S-curve adoption (2026-2029), and OEM-backed NRE payments validating its growth potential.

Parker’s INVS projection: My quantitative is an EE major and says this LIDAR tech is world-class. I tend to believe him. A potential 10 bagger.

Moonshot #2 — Ginkgo Bioworks Holdings, Inc. (NYSE: DNA): Ginkgo Bioworks specializes in cell programming and biosecurity.

Bull Catalysts for Ginkgo Bioworks:

  • Strong platform with $950M in cash

  • 50%+ biopharma revenue growth

  • AI-driven R&D efficiency

  • Direct-to-scientist model boosts engagement

TL;DR – Ginkgo’s stock has been hammered, but it’s pivoting to a CRO model with upfront value creation; still needs growth and cash flow improvements for a turnaround.

Parker’s DNA projection: This chart looks awful, but they are in an existential crisis now with their backs against the wall. I like to bet on people fighting to survive; incentives are aligned and motivation is high. Easy 5x if they turn it around.

Moonshot #3 — Oklo (NYSE: OKLO): Oklo Inc. is an advanced fission power and nuclear fuel recycling company specializing in developing small modular reactors (SMRs) to provide clean, reliable energy solutions.

EGIN -->

Bull Catalysts:

  • 20-year deal with Switch for 12 GW of clean energy

  • Pioneering small modular reactor (SMR) technology

  • Aligned with AI-driven data center demand

  • Backed by prominent investors (e.g., Sam Altman)

  • Regulatory environment increasingly pro-nuclear and NEED CARBON OFFSETS

TL;DR – Oklo recycles nuclear fuel for compact reactors; first reactor set for 2027.

Parker’s OKLO projection: $2.6B market cap; huge upside if demand increases.

Moonshot #4 — AST SpaceMobile, Inc. (NASDAQ: ASTS): AST SpaceMobile is developing the first space-based cellular broadband network.

Bull Catalysts:

  • First-mover in space-based cellular broadband

  • Long-term Vodafone partnership through 2034

  • Successful launch of first five commercial satellites

  • Huge global connectivity potential, especially in remote areas

  • Over $518M in cash (Q3 2024) to fund expansion

TL;DR – ASTS leads space-based cellular broadband, backed by Vodafone, recent satellite deployment, and ample cash to drive future growth.

Parker’s AST projection: 3x-5x play here over the next year; market cap is $6B and if they deliver on their tech the sky is the limit.

Moonshot #5 — Crypto — Worldcoin ($WLD - Ethereum L1): is a cryptocurrency project aimed at creating a global digital identity system and promoting financial inclusion.

Bull Catalysts for WLD:

  • Sam Altman

  • Iris-scanning identity verification

  • Potential universal basic income via crypto distribution

  • Over six million verified users across ~40 countries

  • Aligns with AI’s growing need for “proof-of-personhood”

TL;DR – Founded by Sam Altman (OpenAI CEO), Worldcoin uses iris-based verification to differentiate humans from AI while offering a crypto-based UBI, backed by solid early adoption.

Parker’s WLD projection: Cardano has a $33B market cap and it has no users. Worldcoin has good user growth and is only just under $2B in market cap. With Sam Altman’s backing this chain will be antifragile. A 10x is reasonable for WLD in my view over the next year.

Thanks for reading! If you have suggestions or ideas please let me know!